Over the past five decades, a marked shift in the number of women practicing gynecologic oncology has transformed the field. The specialty began as 57 men gynecologists, who saw an unmet need in the care of women with malignancies of the female genital tract.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
